DNA sequence analysis of three missense mutations affecting colicin E3 bactericidal activity.

Area of Science:

• Bacteriocin research
• Molecular biology
• Protein structure-function analysis

Background:

• Colicin E3 is a bacterial toxin that inhibits protein synthesis in sensitive cells.
• Its activity relies on translocation into the cell and enzymatic cleavage of ribosomal RNA.
• Understanding the structure-function relationship of colicin E3 is crucial for developing novel antibacterial strategies.

Purpose of the Study:

• To determine the nucleotide sequence changes responsible for inactive colicin E3 proteins.
• To elucidate the roles of specific domains in colicin E3 translocation and RNase activity.
• To identify key amino acid residues essential for colicin E3's enzymatic function.

Main Methods:

• Site-directed mutagenesis to introduce specific missense mutations (ceaC1, ceaC2, ceaC3).
• Analysis of nucleotide sequences to identify genetic alterations.
• Assessment of colicin E3 protein function, including membrane translocation and RNase activity.

Main Results:

• The ceaC1 mutation (Ser37Phe) disrupts colicin E3 translocation, confirming the N-terminal domain's role in uptake.
• The ceaC2 (Ser529Leu) and ceaC3 (Gly524Asp) mutations abolish colicin E3 RNase activity.
• These mutations pinpoint critical amino acid residues within the C-terminal enzymatic domain.

Conclusions:

• Specific amino acid changes in colicin E3 lead to loss of function.
• The N-terminal glycine-rich region is vital for bacterial membrane translocation.
• The C-terminal domain contains essential residues for colicin E3's RNase activity.